MYCN and neuroblastoma: Based on the SEER database, it was found that stage 4 disease, unfavorable DNA ploidy, MYCN gene amplification decreased the 5-year survival rates (Coughlan et al., 2017), while age, tumor location, stage are independent prognostic factors for neuroblastoma (Gutierrez et al., 2007).